Treasury Chief Rachel Reeves Aims for Targeted Measures on Household Expenses in Forthcoming Financial Plan
Chancellor Rachel Reeves has stated she is planning "specific steps to address cost of living challenges" in the upcoming financial statement.
Speaking to the BBC, she emphasized that curbing price rises is a joint task of both the administration and the Bank of England.
The UK's inflation rate is expected to be the most elevated among the G7 advanced economies this calendar year and the following year.
Potential Energy Cost Interventions
Reports indicate the government could take action to reduce utility costs, for example by reducing the current 5% rate of value-added tax applied on energy supplies.
Another possibility is to lower some of the regulatory levies currently added to household expenses.
Budgetary Constraints and Analyst Predictions
The government will receive the latest draft from the official forecaster, the OBR, on the start of the week, which will reveal how much room there is for such measures.
The expectation from most economists is that the Chancellor will have to introduce tax increases or expenditure reductions in order to adhere to her declared borrowing rules.
Earlier on Thursday, analysis showed there was a £22 billion gap for the chancellor to address, which is at the lower end of projections.
"There's a joint job between the central bank and the government to continue tackling some of the causes of price increases," Reeves told reporters in Washington, at the annual meetings of the IMF and global financial institution.
Revenue Pledges and International Issues
While a great deal of the focus has been on probable tax increases, the chancellor said the most recent information from the OBR had not changed her commitment to manifesto promises not to raise tax levels on income tax, VAT or social security contributions.
She blamed an "unpredictable global environment" with rising international and commercial issues for the Budget tax moves, probably to be targeted on those "wealthiest."
Global Trade Tensions
Referring to concerns about the UK's economic relations with the Asian nation she said: "The UK's national security invariably are paramount."
Last week's statement by China to increase export controls on rare earths and other resources that are essential for high-technology manufacturing led American leader Donald Trump to suggest an further 100% import tax on imports from the Asian country, raising the prospect of an full-scale commercial conflict between the two economic giants.
The American finance chief labeled China's move "commercial pressure" and "a global supply chain power grab."
Inquired about considering the US offer to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and called on the Chinese government "not to put up barriers and restrict access."
She said the action was "damaging for the world economy and generates further headwinds."
"I believe there are areas where we need to confront China, but there are also significant prospects to trade with China's economy, including financial services and other sectors of the economic system. We've got to achieve that equilibrium appropriate."
The chancellor also stated she was working with other major economies "on our own critical minerals approach, so that we are less reliant."
Health Service Medicine Pricing and Funding
The Chancellor also acknowledged that the cost the National Health Service spends on drugs could go up as a result of current discussions with the US government and its drugs companies, in exchange for lower tariffs and capital.
Some of the world's largest drug companies have said recently that they are either halting or canceling investments in the UK, with some attributing the low prices they are receiving.
Recently, the government science advisor said the price the NHS pays for medicines would have to rise to stop businesses and drug research funding departing from the UK.
Reeves told media: "We have seen because of the cost structure, that drug testing, recent pharmaceuticals have not been available in the UK in the extent that they are in other EU nations."
"We want to make sure that people getting treatment from the National Health Service are able to access the top essential treatments in the globe. And so we are looking at all of that, and... seeking to attract increased capital into the UK."